Private Equity Ownership of US Opioid Treatment Programs This cross-sectional study assesses acquisitions of US opioid treatment programs by private equity firms overall and at the zip-code level.

Profit-driven decision-making worsened the opioid crisis—why would we expect it to fix it? New data show 29% of US opioid treatment programs (OTPs) are owned by private equity, with market concentration raising concerns about access, competition, and quality of care. jamanetwork.com/journals/jam...

👋 Diving into BlueSky! I’m a forensic toxicologist & educator exploring the intersections of science, safety, and society. 🚗💨 Currently researching how d8 & d9 THC affect driving and developing untargeted drug screening methods. Let's connect! #ScienceTwitter2 #ForensicToxicology #CannabisResearch